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The safety of carotid endarterectomy in diabetic
patients: clinical predictors of adverse outcome
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Neal S. Cayne, MD, Patrick J. Lamparello, MD, and Thomas S. Riles, MD, New York, NY
Objectives: Patients with diabetes mellitus have been shown to have an increased incidence of complications after elective
major vascular surgery. The objective of this study was to evaluate a large series of diabetic patients undergoing carotid
endarterectomy (CEA) to determine if outcome differed from nondiabetic patients and to examine predisposing factors
of poor outcome among diabetic patients.
Methods: A retrospective review of a prospectively compiled database was performed. From 1992 through 2000, 2151
CEAs were performed at our institution. Of these, 507 were in diabetic patients (23.6%), and the remaining 1644
procedures were in nondiabetic patients (76.4%).
Results: Diabetic patients were significantly more likely than nondiabetic patients to have hypertension (70.8% vs 64.5%,
P  .01) and cardiac disease (54.6% vs 49.1%, P  .03). They were more likely than nondiabetic patients to be
symptomatic before surgery (52.5% vs 47.1%, P  .04) and to have sustained a preoperative stroke (21.3% vs 17.7%, P 
.07). No differences were noted in other recorded demographic factors or in intraoperative factors between diabetic and
nondiabetic patients. Despite these differences, diabetic patients had similar perioperative outcomes compared with
nondiabetic patients, including perioperative myocardial infarction (0.6% vs 0.4%, PNS), perioperative death (0.8% vs
0.5%, P NS), and perioperative neurologic events such as transient ischemic attack and stroke (3.2% vs 2.4%, P NS).
Among diabetic patients alone, cigarette smoking, general anesthesia, the use of a shunt, and the lack of clamp tolerance
while under regional anesthesia predicted adverse perioperative neurologic outcome, and contralateral occlusion was
associated with increased perioperative mortality.
Conclusions: Despite an increased prevalence of cardiac disease and preoperative neurologic symptoms among diabetic
patients undergoing CEA, the rates of perioperative cardiac morbidity, mortality, and stroke were equal to nondiabetic
patients. In contrast to nondiabetic patients, current cigarette smoking appeared to predict increased adverse neurologic
outcomes among diabetic patients, and the presence of contralateral occlusion among diabetic patients appeared to
predispose them towards increased perioperative mortality. The use of a general anesthetic appeared to increased
perioperative neurologic risk among diabetic patients; however, this may be related to surgeon bias in the selection of
anesthetic technique. Although diabetic patients may have an increase in complications after other major vascular surgical
procedures, the presence of diabetes mellitus does not appear to significantly increase risk. ( J Vasc Surg 2005;42:
878-83.)There is convincing evidence in the literature that
diabetes mellitus (DM) is an independent risk factor for
stroke and myocardial infarction (MI) in the general pop-
ulation.1,2 Carotid endarterectomy (CEA) has been shown
in several prospective, randomized studies to be superior to
medical treatment in the prevention of stroke when patient
selection is appropriate and the perioperative complication
rate is low.3,4 However, some studies have shown that
patients with DM have an increased incidence of complica-
tions after elective major vascular surgery.5-7 Diabetic pa-
tients are often presumed to be at increased risk for MI and
other cardiovascular complications as well as for increased
perioperative mortality. This is particularly notable when
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878open aortic aneurysm surgery8 and lower-extremity revas-
cularization9 are performed.
The status of DM as a predictor of poor outcome after
CEA is less clear. Although a number of studies have
suggested that diabetic patients may be a high-risk popula-
tion in which to perform carotid surgery,10,11 several other
studies specifically addressing this topic have found that
diabetic patients can undergo carotid surgery as safely as
nondiabetic patients.12-14 With these issues in mind, the
objective of this study was to evaluate a large series of
diabetic patients undergoing CEA to determine if outcome
differed from nondiabetic patients undergoing CEA and to
examine predisposing factors of poor outcome among dia-
betic patients.
PATIENTS AND METHODS
A retrospective review was conducted of a prospectively
compiled computerized database of all primary CEAs per-
formed by the Division of Vascular Surgery at the New York
University Medical Center from 1992 through 2000. Reop-
erative carotid operations and combined carotid/coronary
bypass operations were excluded from analysis.
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tion include a preference for regional anesthesia and selec-
tive shunting, empiric shunting for those cases performed
under general anesthesia, and routine patch angioplasty.
Since 1991, most patch angioplasties have been performed
by using knitted polyester; before 1991, the preference was
for saphenous vein.
The choice of anesthetic method was at the discretion
of the operating surgeon. General anesthesia is used most
commonly when a language barrier or severe neurologic
deficit would prohibit effective communication and coop-
eration under regional anesthesia, or because the surgeon
believes a shunt will be used regardless of whether or not
the patient tolerated clamping under regional anesthesia.
Such patients would typically include those with recent
strokes or contralateral strokes, or both, but not necessarily
those with contralateral carotid occlusion alone.
Perioperative events were considered if they occurred
30 days postoperatively. A perioperative MI was diag-
nosed with or without clinical symptoms if accompanied by
either appropriate electrocardiographic findings or cardiac
enzyme indices. All patients routinely had postoperative
electrocardiograms and cardiac enzymes indices. A periop-
erative neurologic event was diagnosed if a patient mani-
fested any focal deficit in the perioperative period, whether
transient or permanent, that prompted either neurologic
consultation, reoperation, or the obtaining of atypical post-
operative imaging studies such as computerized tomogra-
phy scans, magnetic resonance imaging of the brain, cere-
bral angiography or Duplex scans other than those ordered
routinely.
The surgeons at our institution practice an aggressive
approach to any focal neurologic deficit after CEA and
uniformly return the patient immediately to the operating
room. Any focal neurologic event is considered significant,
and we do not observe the patient to determine whether
the event will turn out to be a formal transient ischemic
attack (TIA) or stroke.
Statistical analysis was performed by with SPSS statisti-
cal software (SPSS, Inc, Chicago, Ill). The Fisher’s exact
test or 2 tests, when appropriate, were used for compari-
son of categoric data; P  .05 was considered to be statis-
tically significant.
RESULTS
From 1992 through 2000, 2151 carotid endarterecto-
mies were performed at our institution. Of these, 507 were
in diabetic patients (23.6%), and the remaining 1644 pro-
cedures were in nondiabetic patients (76.4%).
Comparison of demographic factors between dia-
betic and nondiabetic patients. Demographic factors
were compared between diabetic and nondiabetic patients,
and the results are summarized in Table I. Diabetic patients
were significantly more likely to have hypertension (70.8%
vs 64.5%, P  .01) and to have known coronary artery
disease (CAD) (54.6% vs 49.1%, P .03) than nondiabetic
patients. There were no significant differences in gender,smoking history, and prior coronary artery bypass grafting
between diabetic and nondiabetic patients.
Comparison of surgical indications between dia-
betic and nondiabetic patients. Diabetic patients were
significantly more likely than nondiabetic patients to be
symptomatic before surgery (52.5% vs 47.1%, P  .04)
(Table II). They were also more likely than nondiabetic
patients to have sustained a preoperative stroke (21.3% vs
17.7%, P  .07), although this did not reach statistical
significance.
Comparison of intraoperative factors between dia-
betic and nondiabetic patients. There were no significant
differences in surgical management between diabetic and
nondiabetic patients, and these results are summarized in
Table III.
Comparison of outcome between diabetic and non-
diabetic patients. There were no significant differences
noted in the rates of perioperative neurologic events (3.2%
vs 2.4%), MI (0.6% vs 0.4%), and death (0.8% vs 0.5%)
between diabetic and nondiabetic patients (Table IV).
Predictors of postoperative neurologic events among
diabetic patients. Of 16 perioperative neurologic events
among diabetic patients, 2 were fatal strokes, 10 were
completed strokes, and 4 were TIAs. Diabetic patients who
had CEA with regional anesthesia were significantly less
likely to experience a perioperative neurologic event than
diabetic patients who had surgery with general anesthesia
(2.2% vs 6.7%, P  .03). Diabetic patients who were
smokers were significantly more likely to experience a peri-
operative neurologic event after CEA than nonsmokers
Table I. Comparison of patient demographics between
diabetic and nondiabetic patients
Diabetics
(n  507)
Nondiabetics
(n  1644) P
Gender (% male) 62.1 58.5 NS
Hypertension 70.8 64.5 .01
CAD 54.6 49.1 .03
Cigarette smoking 25.4 28.4 NS
Local 79.3 79.9 NS
Prior CABG 24.8 21.5 NS
NS, not significant; CAD, coronary artery disease; CABG, coronary artery
bypass grafting.
Table II. Comparison of indications for carotid
endarterectomy between diabetic and nondiabetic
patients
Diabetics
(n  507)
Nondiabetics
(n  1644) P
Preoperative ipsilateral neurologic
symptoms (TIA or stroke) 52.5 47.1 .04
Preoperative stroke 21.3 17.7 .07
Contralateral carotid occlusion 10.3 11.6 NS
TIA, Transient ischemic attack; NS, not significant.(6.5% vs 2.2%, P  .03). Diabetic patients who did not
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whom a shunt was used during surgery also experienced
significantly increased rates of perioperative neurologic
events after CEA. No significant differences were noted
among the following factors and perioperative neurologic
events among diabetic patients: gender, hypertension,
CAD, contralateral occlusion, preoperative symptom sta-
tus, and preoperative stroke (Table V).
Multivariate analysis using logistic regression was per-
formed to attempt to identify independent predictors of
postoperative neurologic deficits. All factors significant to
P  .2 on univariate analysis were included (shunt, smok-
ing, preoperative symptoms, local anesthesia, clamp toler-
ance). The only factor that remained significant on the
Table III. Comparison of surgical management between
diabetic and nondiabetic patients
Diabetics
(n  507)
Nondiabetics
(n  1644) P
Regional anesthesia 79.3 79.9 NS
Tolerated carotid clamping* 87.7 90.1 NS
Shunted under regional
anesthesia 12.3 9.9 NS
Total shunt utilized† 34.5 33.3 NS
*Denominator includes only patients who had surgery under regional
anesthetic.
†Includes both patients selectively shunted under regional anesthesia, and
empirically shunted under general anesthesia.
Table IV. Comparison of perioperative complications
between diabetic and nondiabetic patients
Diabetics
(n  507)
Nondiabetics
(n  1644) P
Perioperative MI 0.6 0.4 NS
Perioperative death 0.8 0.5 NS
Perioperative stroke 3.2 2.5 NS
MI, myocardial infarction; NS, not significant.
Table V. Univariate relationship of variables with
perioperative stroke in diabetic patients
Factor
Perioperative
stroke rate
with factor
Perioperative
stroke rate
without factor P
Male gender 2.6 4.3 NS
Hypertension 3.4 2.1 NS
Coronary disease 3.3 3.1 NS
Smoking 6.5 2.2 .03
Preoperative CVA 3.7 3.0 NS
Asymptomatic 2.1 4.1 NS
Contralateral occlusion 3.8 2.9 NS
Regional anesthesia 2.2 6.7 .03
Shunt used 6.9 1.2 .001
Clamp tolerant 1.1 10.0 .001
CVA, Cerebrovascular accident.multivariate analysis was the use of a shunt (P  .02).Predictors of postoperative MI among diabetic
patients. No significant differences were noted among the
following factors and perioperative MI among diabetic
patients: gender, hypertension, CAD, contralateral occlu-
sion, preoperative symptom status, anesthetic method, and
preoperative strokes (Table VI).
Predictors of postoperative mortality among dia-
betic patients. Among four perioperative deaths in dia-
betic patients, two were secondary to fatal strokes, one
secondary to a fatal MI, and one secondary to respiratory
failure. Diabetic patients with contralateral total carotid
occlusion were more likely to experience perioperative
mortality than those with a patent contralateral artery (3.8%
vs 0.5%, P  .06). Diabetic patients who did not tolerate
clamping under regional anesthesia and those in whom a
shunt was used during surgery also experienced signifi-
cantly increased perioperativemortality rates after CEA.No
significant differences were noted among the following
factors and perioperativemortality among diabetic patients:
gender, hypertension, CAD, smoking, preoperative symp-
tom status, anesthetic method, and preoperative strokes
(Table VII).
Multivariate analysis using logistic regression was per-
formed to attempt to identify independent predictors of
postoperative death. All factors significant to P  .2 on
univariate analysis—preoperative cerebrovascular accident,
preoperative symptoms, local anesthesia, shunt, clamp tol-
erance, and contralateral occlusion—were included. Likely
due to the small number of postoperative deaths, none of
these factors remained significant on the logistic regression
analysis.
DISCUSSION
DM is clearly an important risk factor for stroke,1,2 and
as such, diabetic patients might be expected to derive
particular benefit from CEA. However, patients undergo-
ing CEA only attain meaningful clinical benefits when the
perioperative complication rates are exceedingly low3,4;
Table VI. Univariate relationship of variables with
perioperative myocardial infarction among diabetic
patients
Factor
Perioperative
MI rate with
factor
Perioperative
MI rate
without factor P
Male gender 0.7 0.5 NS
Hypertension 0.8 0.0 NS
Coronary disease 1.1 0 NS
Smoking 1.6 0.3 NS
Contralateral occlusion 0.0 0.7 NS
Preoperative CVA 0.9 0.5 NS
Asymptomatic 0.4 0.7 NS
Regional anesthesia 0.2 1.9 NS
Shunt used 1.1 0.3 NS
Clamp tolerant 0.3 0.0 NS
MI, Myocardial infarction; CVA, cerebrovascular accident.therefore, any increased perioperative risk in the diabetic
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selection is concerned. Unfortunately, the literature is not
clear on the matter of potentially increased risk in diabetic
patients undergoing carotid surgery. Patients withDMmay
have an increased risk both of MI and other cardiovascular
complications as well as of perioperative neurologic mor-
bidity.
Several previous studies have demonstrated that dia-
betic patients undergoing CEA have a higher prevalence of
CAD than nondiabetic patients.5,15 The current study adds
further evidence that this is so. Additionally, it is well
known that CAD in diabetic patients may be occult. MI is
the most common cause of death after CEA overall6,16,17;
therefore, it would not be unexpected for diabetic patients
to have increased cardiac morbidity after CEA. The litera-
ture remains divided on this topic, however. Axelrod et al5
and other investigators6,7 found that diabetic patients had a
significantly higher incidence of death or cardiovascular
complications after CEA (3.5% vs 2.5%, P  .023). In
contrast, Hamdan et al18 analyzed 6565 major vascular
operations and found that DM alone did not confer a
higher rate of cardiac morbidity or perioperative mortality;
however, long-term survival among diabetic patients was
significantly reduced.
The literature is similarly divided on whether diabetic
patients have an increased risk of perioperative neurologic
morbidity after CEA. Ahari et al19 found that diabetic
patients had a higher 30-day and 1-year mortality after
CEA compared with nondiabetic patients, again, predom-
inantly because of cardiac complications. However, post-
operative neurologic morbidity did not differ between the
two patient groups. In contrast, Tu et al20 found that DM
was a significant independent predictor for 30-day death or
stroke after CEA (odds ratio, 1.28; 95% confidence inter-
val, 1.01 to 1.63). Similarly, Kragsterman et al21 found that
DM was a significant risk factor for both perioperative
stroke and death after CEA.
Three additional recent studies have specifically ad-
dressed the question of whether diabetic patients are at
Table VII. Univariate relationship of variables associated
with perioperative death in diabetic patients
Factor
Perioperative
death rate
with factor
Perioperative
death rate
without factor P
Male gender 0.7 1.1 NS
Hypertension 0.6 1.4 NS
Coronary disease 0.7 0.9 NS
Smoking 1.6 0.5 NS
Preoperative CVA 1.9 0.5 NS
Asymptomatic 0 1.5 NS
Contralateral occlusion 3.8 0.5 .06
Regional anesthesia .5 1.9 NS
Shunt used 2.3 0 .014
Clamp tolerant 0 4.0 .015
CVA, cerebrovascular accident.increased risk after CEA. Akbari et al12 reported on 732CEAs, of which 284 were in diabetic patients (39%). There
were no significant differences in perioperative stroke or
mortality between the two patient groups. Pistolese et al13
reviewed 781CEAs, of which 193 were in diabetic patients.
There were no significant differences in perioperative
stroke, MI, mortality, or long-term survival between dia-
betic and nondiabetic patients undergoing CEA. Finally,
Ballotta et al14 reported on 547 CEAs, of which 199 were
in diabetic patients (36.4%). Perioperative neurologic and
cardiac morbidity rates were comparable in the two patient
groups, as were long-term rates of recurrent stenosis and
occlusion. In a series from our institution regarding the
cause of perioperative neurologic events after CEA, dia-
betic patients were found to have similar perioperative
neurologic event rates compared with nondiabetic patients
(3.6% vs 2.2%, P  NS); even in diabetic patients, most of
the strokes were related to technical imperfections in the
operation’s performance.22
The current study adds support to these previous stud-
ies in finding no significant differences in major outcome
parameters between diabetic and nondiabetic patients un-
dergoing CEA. In current study, we have confirmed that
DM in itself does not confer significantly increased risk and
that CEA may be accomplished safely in this patient popu-
lation. This is despite the increased incidence of known
preoperative risk factors in diabetic patients, such as preop-
erative neurologic symptoms, hypertension, and CAD.
However, risk of perioperative complications in dia-
betic compared with nondiabetic patients was mildly in-
creased, although this did not reach statistical significance.
It is possible that even with the large number of patients in
this study, the extremely low incidence of overall compli-
cations is rendering it difficult to demonstrate a statistically
significant difference when one in fact exists. Therefore, in
contrast to previous studies regarding this topic, and de-
spite the lack of apparent significant difference in outcomes
between diabetic and nondiabetic patients, we decided to
examine specific predictors of poor outcome among dia-
betic patients in more detail.
When univariate predictors of perioperative neurologic
events among diabetic patients were examined, general
anesthesia, smoking, the use of a shunt, and the lack of
clamp tolerance under regional anesthesia significantly in-
creased the risk of this complication. Inherent patient fac-
tors such as contralateral occlusion and the presence of
preoperative neurologic symptoms did not significantly
increase the risk of a neurologic event, although these
factors are typically mentioned as high-risk factors among
the general CEA population. The finding of cigarette
smoking as a predictor of perioperative stroke among dia-
betic patients is novel; this finding could not be duplicated
among the nondiabetic patient population. It is possible
that patients who continue to smoke at the time of opera-
tion have an increased burden of intracranial small vessel
disease, making themmore prone to clinically manifesting a
perioperative ischemic insult.
Although general anesthesia appeared to increase the
risk of a neurologic event, it is likely that there is significant
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general anesthesia; many are patients who have sustained
preoperative strokes or have contralateral occlusion, or
both. A recent study from our institution found that pa-
tients who underwent surgery with general anesthesia were
found to be a higher-risk subgroup, with an increased
prevalence of both contralateral carotid occlusion and pre-
operative stroke.24 This patient group would likely be at
increased risk for a neurologic event based on these innate
factors. Alternatively, diabetic patients, who have an in-
creased burden of cerebrovascular disease as manifested by
an increased prevalence of preoperative symptoms and pre-
operative stroke, may benefit from the precise and constant
neurologic monitoring during CEA that occurs under re-
gional anesthesia.
Similarly, the use of a shunt itself is obviously interre-
lated with the method of anesthesia at our institution.Most
of the patients in whom shunts are used receive a general
anesthetic; the remainder are those who do not tolerate
carotid clamping under regional anesthesia. Finally, the
lack of clamp tolerance under regional anesthesia again
would be more likely in patients with contralateral occlu-
sion and those who have sustained a preoperative stroke.
The only factor that remained significant on the multivari-
ate analysis was the use of a shunt. It is likely that this
finding is influenced by the several patients who experi-
enced intraoperative ischemia under regional anesthesia
that did not ultimately respond to shunt insertion and by
the strokes that occurred under general anesthesia. No
technical problems were related to shunt insertion in this
series. We therefore do not believe that the shunt insertion
itself caused any perioperative neurologic deficits in this
series.
There were no significant univariate predictors of peri-
operative MI among diabetic patients. This may be second-
ary to the extremely low incidence of postoperative MI in
general among our CEA population, most of which are
accomplished with regional anesthesia. When perioperative
mortality among diabetic patients was examined, the only
significant univariate predictors of mortality were the use of
a shunt and the lack of clamp tolerance under regional
anesthesia. As these factors predicted perioperative neuro-
logic events, and half of the perioperative deaths were
secondary to fatal strokes, it is not surprising that these
factors would predict perioperative death as well. However,
it should be noted that the raw numbers involved in these
analyses are extremely small.
Contralateral total occlusion was also found to be a
predictor of postoperative mortality among diabetic pa-
tients (P  0.06). It is unclear why contralateral occlusion
should be a predictor of perioperative death among diabetic
patients when it did not appear to be a significant predictor
of a postoperative neurologic event. In contrast, a recent
study from our institution found that contralateral occlu-
sion was not a significant risk factor for poor outcome
among the general CEA population.23CONCLUSIONS
Despite an increased prevalence of coronary artery dis-
ease and preoperative neurologic symptoms among dia-
betic patients undergoing CEA, the rates of perioperative
neurologic events, MI, and mortality were essentially equal
to those of nondiabetic patients. In contrast to nondiabetic
patients, current cigarette smoking appeared to predict
increased adverse neurologic outcomes among diabetic
patients, and the presence of contralateral occlusion among
diabetic patients appeared to predispose them towards in-
creased perioperative mortality. The use of a general anes-
thetic appeared to increased perioperative risk among pa-
tients with DM, but this may be related to surgeon bias in
the selection of anesthetic technique. Although diabetic
patients may have an increase in complications after other
major vascular surgical procedures, the presence of DM
does not appear to significantly increase risk after CEA.
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